(Q36637482)

English

Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses

scientific article published on October 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

0 references

1 reference

Europe PubMed Central

Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

anti-retroviral agent

0 references

0 references

Laurie Hoyt Huffman

3

object named as

Laurie Hoyt Huffman

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

P Todd Korthuis

4

object named as

P Todd Korthuis

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

author name string

Roger Chou

1

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Rongwei Fu

2

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

language of work or name

0 references

publication date

1 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

368

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

9546

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1503-1515

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Progression to AIDS or death as endpoints in HIV clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative synthesis in systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Nevirapine or efavirenz combined with two nucleoside reverse transcriptase inhibitors compared to HAART: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Indirect comparisons of competing interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Explaining heterogeneity in meta-analysis: a comparison of methods.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Transition From Meeting Abstract to Full-length Journal Article for Randomized Controlled Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Empirical assessment of effect of publication bias on meta-analyses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination antiretroviral therapy and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of the literature or of individual patient data: is there a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of Reporting of Randomized Trials as a Measure of Methodologic Quality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationship between study design, results, and reporting of randomized clinical trials of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Better reporting of harms in randomized trials: an extension of the CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969638-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(06)69638-4

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36637482&oldid=2158626488"